other
confidence high
sentiment neutral
materiality 0.05
Citius Oncology files prospectus supplement to update S-1 registration statement following 10-Q filing
CITIUS ONCOLOGY, INC.
- Prospectus supplement filed August 18, 2025; original S-1 effective July 15, 2025.
- Public offering of common stock and warrants closed July 17, 2025.
- Supplement needed because Citius Oncology not yet eligible to incorporate 10-Q by reference into S-1.